Paper4574155
FL-1060: a new penicillin with a unique mode of action.
Park JT and 1 other. Biochem Biophys Res Commun, 1973. Cited by 119 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. FL-1060: a new penicillin with a unique mode of action. Papers, record 4574155. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4574155
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Escherichia coli | Major topic |
| Penicillins | Major topic |
| Ampicillin | |
| Penicillin Resistance | |
| Peptides | |
| Peptidoglycan |
Source PubMed
Cited by63
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 119 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37,883,451 | Recovery of Vibrio cholerae polarized cellular organization after exit from a non-proliferating spheroplast state. | PLoS One | 2023 | https://conductscience.org/library/papers/37883451 | PubMed |
| 32,155,044 | Harnessing β-Lactam Antibiotics for Illumination of the Activity of Penicillin-Binding Proteins in Bacillus subtilis. | ACS Chem Biol | 2020 | https://conductscience.org/library/papers/32155044 | PubMed |
| 32,024,974 | Permanent control of HIV-1 pathogenesis in exceptional elite controllers: a model of spontaneous cure. | Sci Rep | 2020 | https://conductscience.org/library/papers/32024974 | PubMed |
| 28,644,060 | Lytic transglycosylases: concinnity in concision of the bacterial cell wall. | Crit Rev Biochem Mol Biol | 2017 | https://conductscience.org/library/papers/28644060 | PubMed |
| 26,263,980 | Validation of FRET Assay for the Screening of Growth Inhibitors of Escherichia coli Reveals Elongasome Assembly Dynamics. | Int J Mol Sci | 2015 | https://conductscience.org/library/papers/26263980 | PubMed |
| 22,216,505 | Factors influencing the absorption and disposition of mecillinam and pivmecillinam in man. | Br J Clin Pharmacol | 1976 | https://conductscience.org/library/papers/22216505 | PubMed |
| 20,545,860 | Septal and lateral wall localization of PBP5, the major D,D-carboxypeptidase of Escherichia coli, requires substrate recognition and membrane attachment. | Mol Microbiol | 2010 | https://conductscience.org/library/papers/20545860 | PubMed |
| 20,041,868 | Beta-lactam antibiotics: from antibiosis to resistance and bacteriology. | APMIS | 2010 | https://conductscience.org/library/papers/20041868 | PubMed |
| 18,390,656 | Growth of Escherichia coli: significance of peptidoglycan degradation during elongation and septation. | J Bacteriol | 2008 | https://conductscience.org/library/papers/18390656 | PubMed |
| 17,640,276 | The essential peptidoglycan glycosyltransferase MurG forms a complex with proteins involved in lateral envelope growth as well as with proteins involved in cell division in Escherichia coli. | Mol Microbiol | 2007 | https://conductscience.org/library/papers/17640276 | PubMed |
| 15,090,499 | Restricted Mobility of Cell Surface Proteins in the Polar Regions of Escherichia coli. | J Bacteriol | 2004 | https://conductscience.org/library/papers/15090499 | PubMed |
| 12,107,141 | Role of the murein precursor UDP-N-acetylmuramyl-L-Ala-gamma-D-Glu-meso-diaminopimelic acid-D-Ala-D-Ala in repression of beta-lactamase induction in cell division mutants. | J Bacteriol | 2002 | https://conductscience.org/library/papers/12107141 | PubMed |
| 11,418,550 | Constitutive septal murein synthesis in Escherichia coli with impaired activity of the morphogenetic proteins RodA and penicillin-binding protein 2. | J Bacteriol | 2001 | https://conductscience.org/library/papers/11418550 | PubMed |
| 7,027,927 | Murein synthesis and beta-lactam antibiotic susceptibility during rod-to-sphere transition in a pbpA(Ts) mutant of Escherichia coli. | Antimicrob Agents Chemother | 1981 | https://conductscience.org/library/papers/7027927 | PubMed |
| 7,007,327 | Effects of furazlocillin, a beta-lactam antibiotic which binds selectively to penicillin-binding protein 3, on Escherichia coli mutants deficient in other penicillin-binding proteins. | J Bacteriol | 1981 | https://conductscience.org/library/papers/7007327 | PubMed |
| 6,965,440 | Penicillin-binding proteins of Streptomyces cacaoi, Streptomyces olivaceus, and Streptomyces clavuligerus. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/6965440 | PubMed |
| 6,841,320 | Streptococcus faecium ATCC 9790 penicillin-binding proteins and penicillin sensitivity are heavily influenced by growth conditions: proposal for an indirect mechanism of growth inhibition by beta-lactams. | J Bacteriol | 1983 | https://conductscience.org/library/papers/6841320 | PubMed |
| 6,754,708 | Colicin M is an inhibitor of murein biosynthesis. | J Bacteriol | 1982 | https://conductscience.org/library/papers/6754708 | PubMed |
| 6,297,386 | Effect of protein synthesis inhibition on the induction of cell lysis in Escherichia coli by mecillinam plus nocardicin A. | Antimicrob Agents Chemother | 1982 | https://conductscience.org/library/papers/6297386 | PubMed |
| 6,293,397 | Murein and lipopolysaccharide biosynthesis in synchronized cells of Escherichia coli K 12 and the effect of penicillin G, mecillinam and nalidixic acid. | Arch Microbiol | 1982 | https://conductscience.org/library/papers/6293397 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4574155
GET https://conductscience.org/api/papers/v1/4574155/cited_by?page=2